Hi, what are you looking for?
Here is our list of the ten companies that made the biggest or at least the most headlines this past year, for good...
– The decision gives Teva more time to transfer patients to its better patent protected double dosage Copaxone. – Teva Pharmaceutical Industries Ltd. (NYSE:...
George Soros’ 13F might cause even the most brazen bulls to start to wonder if Soros thinks Armageddon is near. After a 5 year...
– The company is responsible for 10% of the trading turnover on the Tel Aviv 25 Index. /By Gali Weinreb and Tali Tsipori/ ...
– The pharmaceutical firm is seeking a merger at a good premium on its $20 billion market cap. – Sources inform “Globes” that pharmaceutical...
– My instinctive reaction to Monday’s tragic news was to not write a positive news blog this week. But why let the terrorists win? Dry Bones’ cartoon included...
– – Last year, Rami Levy joined BTI, the group of businesspeople that supports peace with the Palestinians for the sake of the economy....
– VBL is developing drugs for the treatment of cancer and inflammatory diseases. On Friday, VBL Therapeutics Ltd. (formerly Vascular Biogenics) published a draft prospectus...
– The European Patent Office ruled in favor of Teva in a patent opposition proceeding filed by Synthon and Mylan. – Teva Pharmaceutical...
– Novartis had signed an MOU to acquire the stem cell treatment company for up to $600 million. – Elbit Medical Technologies Ltd. (TASE:EMTC)...